CATALYSIS Advises Point-of-Care Diagnostic Developer Åmic AB in Sale to Johnson & Johnson Nordic AB
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive strategic advisor to Åmic AB in its sale to Johnson & Johnson Nordic AB, a Johnson & Johnson company. Financial terms were not disclosed.
CATALYSIS Advises Point-of-Care Diagnostic Developer Åmic AB in SEK 102 Million Financing
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive financial advisor to Åmic AB in a Preferred Series C financing raising SEK 102 million. The investors included funds advised by Investor Growth Capital AB, Innovations Kapital AB and Johnson & Johnson Development Corporation.
Hingge Hsu, MD Joins CATALYSIS as Senior Advisor
CATALYSIS CAPITAL PARTNERS is pleased to announce that Dr. Hingge Hsu has joined CATALYSIS as a Senior Advisor. Dr. Hsu has contributed to innovation in the life science industry for more than two decades, most recently as a Managing Director in the Private Equity Group at Lehman Brothers in New York, responsible for its healthcare […]